Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 VEGF polymorphisms in gastrointestinal cancer cell lines

From: Biomarkers for antitumor activity of bevacizumab in gastric cancer models

  Genotype
  Polymorphic site
Cell line -2578 -1154 -634 936
MKN-45 A/A A/A G/G T/T
4-1ST C/A G/A G/G C/C
GXF97 C/A G/A C/G C/C
MKN-28 C/C G/A C/C C/C
SC-09-JCK C/C G/A G/G C/C
SC-08-JCK C/C G/A C/C T/T
NCI-N87 C/A G/A G/G C/C
SC-10-JCK C/A G/A G/G C/T
SCH C/C G/A C/G C/C
  1. VEGF polymorphisms (-2578, -1154, -634 and 936 on VEGF genomic DNA) were examined by using LightCycler™